Email this article ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY
- Authors: Yakusevich V.V.1, Petrochenko A.S.1, Simonov V.S.1, Levshin N.Y.1, Deev A.D.2
-
Affiliations:
- Yaroslavl State Medical Academy, Ministry of Health and Social Development of Russia
- State Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia
- Issue: Vol 5, No 4 (2011)
- Pages: 64-70
- Section: PHARMACOTHERAPY
- Published: 16.07.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/87
- DOI: https://doi.org/10.17650/1818-8338-2011-4-64-70
- ID: 87
Cite item
Full Text
Abstract
Objective — to study therapeutic equivalence (efficacy, safety and tolerability) and hemorheological activity of original clopidogrel and its
generic in patients of high cardiovascular risk.
Materials and methods. 50 patients with stable angina pectoris were randomized into 2 groups of consecutive 2-week treatment by original
(plavix) and generic (plagril) clopidogrel and vice versa. ADP-induced platelet aggregation was measured at baseline and after treatment by
each of the drugs. Physical examination and adverse events were evaluated at visits.
Results. After the first treatment period a significant decrease of platelet aggregation was determined in both groups. After switching to another
drug the decrease continued but not significantly in both groups. There were registered no adverse events associated with antiplatelet therapy.
Conclusion. Equal antiplatelet activity established for plavix and plagril demonstrates their therapeutic equivalence.
Keywords
About the authors
V. V. Yakusevich
Yaroslavl State Medical Academy, Ministry of Health and Social Development of Russia
Author for correspondence.
Email: yakusevich@yandex.ru
Russian Federation
A. S. Petrochenko
Yaroslavl State Medical Academy, Ministry of Health and Social Development of RussiaRussian Federation
V. S. Simonov
Yaroslavl State Medical Academy, Ministry of Health and Social Development of RussiaRussian Federation
N. Yu. Levshin
Yaroslavl State Medical Academy, Ministry of Health and Social Development of RussiaRussian Federation
A. D. Deev
State Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaRussian Federation
References
Supplementary files
